PAM
NPCE icon

Panagora Asset Management’s Neuropace NPCE Stock Holding History

Panagora Asset Management’s Portfolio NPCE Stock Details NPCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.81M Sell
114,059
-216
-0.2% -$3.48K 0.01% 656
2026
Q1 		$1.5M Buy
114,275
+56,267
+97% +$844K 0.01% 635
2025
Q4 		$896K Sell
58,008
-1,687
-3% -$22.6K ﹤0.01% 749
2025
Q3 		$615K Sell
59,695
-40,094
-40% -$378K ﹤0.01% 758
2025
Q2 		$1.11M Buy
+99,789
New +$1.25M 0.01% 605

Other funds holding NPCE

PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Panagora Asset Management's NPCE Position: Q2 2026 in Review

Panagora Asset Management reduced its Neuropace (NPCE) stake by 0.19% in Q2 2026, selling an estimated $3.48K and leaving 114,059 shares worth $1.81M. The position accounts for 0.01% of the portfolio, ranked #656.

Panagora Asset Management first reported a position in NPCE in Q2 2025 and has held it in 5 quarters since. 112 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • Panagora Asset Management held 114,059 shares of Neuropace worth $1.81M as of Q2 2026.
  • Panagora Asset Management sold 216 Neuropace shares in Q2 2026, an estimated $3.48K.
  • Neuropace made up 0.01% of Panagora Asset Management's portfolio in Q2 2026, its #656 holding.
  • Panagora Asset Management first reported a position in Neuropace in Q2 2025 and has held it in 5 quarters since.
  • 112 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.